GUIDED THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GUIDED THERAPEUTICS, INC. (GTHP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.14 per share for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-11-13
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $0.26.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $0.47.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $0.47, a 0.00% change from fiscal 2021.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $0.47, a 2.08% decline from fiscal 2020.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $0.48.
- GUIDED THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $0.49, a 22.50% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $0.14 10-Q · filed 2025-11-13 | ||||
| 2024-09-30 | $0.12 10-Q · filed 2025-11-13 | ||||
| 2023-06-30 | $0.26 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | $0.26 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $0.47 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | $0.47 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | $0.47 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $0.47 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $0.47 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $0.47 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $0.48 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $0.48 10-Q · filed 2021-11-15 | ||||
| 2015-12-31 | $0.49 10-K · filed 2016-03-15 | ||||
| 2014-12-31 | $0.40 10-K · filed 2016-03-15 | ||||
| 2013-12-31 | $0.69 10-K · filed 2015-03-25 | $1.18 10-K · filed 2013-03-27 | |||
| 2012-12-31 | $0.76 10-K · filed 2014-03-26 |